Myocardial Viability Testing in the Management of Ischemic Heart Failure

Area of Science:

• Cardiology
• Medical Imaging
• Heart Failure Research

Background:

• Ischemic heart failure remains a leading cause of mortality and disability despite medical advances.
• Viable myocardium signifies reversible left ventricular dysfunction, a key factor in treatment decisions.
• Coronary revascularization can enhance left ventricular function and prognosis in patients with viable myocardium.

Purpose of the Study:

• To review the concept of viable myocardium and its significance in ischemic heart failure.
• To explore the role and available tools for myocardial viability testing.
• To discuss current research, controversies, and a patient-centered approach for clinical practice.

Main Methods:

• Literature review of current knowledge on myocardial viability.
• Analysis of imaging modalities used for viability assessment (e.g., dobutamine stress echocardiography, nuclear imaging, MRI).
• Discussion of clinical trial data and controversies surrounding viability testing.

Main Results:

• Viability testing is important for selecting patients for revascularization, particularly those with multi-vessel coronary artery disease and impaired left ventricular function.
• Several imaging modalities effectively assess myocardial viability and predict functional recovery post-revascularization.
• Despite potential benefits, the routine use of viability testing in managing ischemic heart failure remains debated due to inconclusive trial results.

Conclusions:

• Myocardial viability assessment is a critical component in the decision-making process for coronary revascularization in ischemic heart failure.
• While imaging techniques are advanced, further research is needed to clarify the definitive role of viability testing in improving patient outcomes.
• A patient-centered approach is essential for integrating viability testing into clinical practice for ischemic heart failure management.